(Q37821354)

English

Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers

scientific article published on 16 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

endometrial stromal sarcoma

1 reference

based on heuristic

inferred from title

uterine carcinosarcoma

1 reference

based on heuristic

inferred from title

stromal sarcoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Riitta Koivisto-Korander

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Ralf Butzow

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Anna-Maija Koivisto

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Arto Leminen

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

451-459

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Immunohistochemical analysis of gynecologic tumors

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Recent advances in immunohistochemistry in gynaecological pathology

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Uterine sarcomas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Uterine sarcomas: a review

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Immunohistochemical analysis of p53 protein in uterine sarcomas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

CD44, a therapeutic target for metastasising tumours

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

MIB-1 in endometrial carcinoma: prognostic significance with 5-year follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0138-1

21 January 2018

Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine sarcoma: steroid receptors and response to hormonal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and outcome in women with uterine sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 expression in soft tissue sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct subtypes of serous ovarian carcinoma identified by p53 determination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161468

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-010-0138-1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37821354&oldid=2200982304"